↓ Skip to main content

A real-world study of PARP inhibitors in 75 patients with platinum-sensitive recurrent ovarian cancer from China

Overview of attention for article published in Frontiers in oncology, January 2024
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
5 Mendeley